|
End-of-day quote
Korea S.E.
2026-09-02
|
5-day change | 1st Jan Change | ||
| 5,630.00 KRW | -4.41% |
|
+1.44% | -17.45% |
| Dec. 09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.41% | +1.44% | +22.39% | +0.90% | -17.45% | -23.92% | - | - | - | 102M | |
| +1.37% | -3.93% | +21.44% | +52.85% | +41.94% | +92.02% | +420.10% | +163.14% | +3,084.77% | 46.24B | |
| +1.24% | -1.21% | +7.26% | +28.70% | +32.20% | +21.14% | +60.55% | +7.56% | +140.84% | 26.57B | |
| +0.40% | -6.42% | -13.87% | +0.11% | -16.81% | -17.28% | -41.44% | -57.01% | -16.40% | 6.94B | |
| +0.24% | -1.01% | +18.69% | +39.39% | +6.10% | +7.67% | +132.42% | +141.24% | +981.43% | 5.94B | |
| +0.61% | -1.09% | +0.57% | +22.75% | +29.24% | +18.71% | +74.09% | -7.10% | +229.99% | 3.35B | |
| +2.25% | -3.95% | +33.19% | +63.22% | -33.32% | -32.35% | +1,829.25% | -73.43% | - | 2.53B | |
| -0.29% | +0.17% | +13.80% | +71.94% | +47.96% | +97.50% | +14.70% | -65.92% | +117.50% | 2.24B | |
| +5.30% | +5.41% | +14.76% | +28.31% | +31.13% | +29.15% | +33.54% | -11.62% | +8.70% | 2.03B | |
| -2.60% | -5.64% | -4.14% | +3.38% | -6.17% | -13.69% | -55.31% | -74.41% | - | 1.88B | |
| -2.78% | -6.20% | -2.19% | +1.02% | +12.62% | +3.18% | -21.26% | -37.76% | -45.21% | 1.67B | |
| -1.19% | +0.56% | +10.17% | +12.46% | +39.59% | +43.70% | +193.17% | - | - | 1.63B | |
| +0.76% | -5.30% | +2.62% | +4.42% | +1.95% | -8.64% | +30.93% | +6.58% | -30.13% | 1.26B | |
| +11.18% | +11.92% | +28.03% | +20.71% | +34.13% | +24.26% | -6.63% | -56.67% | -81.89% | 1.13B | |
| -2.51% | -4.84% | -0.55% | +10.35% | +29.14% | +29.79% | +221.67% | +35.44% | +173.52% | 991M | |
| -2.32% | -9.36% | +12.74% | +1.77% | +7.98% | -6.70% | -35.20% | -71.39% | - | 885M | |
| +0.41% | +1.94% | +4.24% | +4.69% | -4.53% | +1.24% | +25.77% | -17.56% | +54.64% | 866M | |
| -1.28% | -2.87% | +23.49% | +15.46% | +17.08% | +10.17% | -23.68% | - | - | 650M | |
| -2.13% | -1.29% | +7.48% | +11.65% | -9.45% | -19.58% | -23.59% | -48.78% | +46.50% | 624M | |
| +2.30% | +1.16% | +21.09% | +7.17% | -23.72% | -10.17% | -38.57% | -78.71% | - | 539M | |
| Average | +0.33% | -1.36% | +11.06% | +20.06% | +10.98% | +12.31% | +146.87% | -14.49% | +358.79% | 5.4B | |
| Weighted average by Cap. | +1.07% | -3.21% | +13.27% | +36.93% | +28.09% | +47.00% | +248.90% | +70.31% | +1,534.03% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions
